Remove 2014 Remove Blogging Remove Invest Remove San Diego
article thumbnail

RiverVest Venture Closes $184M Fund for Backing Healthcare Ventures

Xconomy

Louis, MO-based venture capital firm with additional offices in San Diego, CA, and Cleveland, OH, has raised $184.4 million for its fourth fund dedicated to investing in healthcare companies. Since its launch, RiverVest has invested in 47 companies working to develop new drugs and medical devices.

San Diego 107
article thumbnail

Xconomy Special Report: 12 San Diego Tech Startup to Watch in 2017

Xconomy

I started with a list of companies already screened by the San Diego Venture Group’s annual venture summit, and consulted with investors and startup mentors to refine the list. million in a Series D round of investment capital, according to founder and chairman Tony Farwell. Financial terms were not disclosed.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Turning Point Therapeutics Plans IPO to Advance Targeted Cancer Drugs

Xconomy

The company, which started operations in 2014, has raised nearly $148 million since inception. The San Diego biotech is developing what it describes as a “next-generation” drug as a treatment for cancers associated with genetic variations that alter the enzymes ALK, ROS1, and TRK.

article thumbnail

With New Cash, Sensemetrics Aims to Take Industrial IoT Tech Global

Xconomy

San Diego startup Sensemetrics is applying that technology to the industrial Internet-of-things sector (IIoT), selling access to its cloud platform to the world’s largest mining companies and government agencies monitoring major infrastructure, such as dams. CEO Matt Meehan says Sensemetrics.

article thumbnail

Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections

Xconomy

San Diego-based Qpex has raised $33 million to advance The Medicines Company’s (NASDAQ: MDCO ) old preclinical compounds toward human testing. He had joined the Parsippany, NJ, drug maker when it bought Rempex Pharmaceuticals in 2014. New Enterprise Associates led the Series A round. That company was developing.

article thumbnail

Profitability Helps San Diego Lender Step Out from Industry Cloud

Xconomy

In contrast to some alternative lenders, the San Diego firm said it is growing fast and is consistently profitable. The company became a Wall Street darling when it raised $1 billion-plus through its 2014 IPO, and now claims to have deployed roughly $19 billion in loans since inception.

article thumbnail

Drug-Hunting Startup From Scripps Attracts Celgene Alum, $50M Backing

Xconomy

A team of decorated academic chemists in San Diego have been working since 2014 on a biotech startup that aims to find new drugs faster. Vividion Therapeutics is launching with $50 million pledged from investment firms Arch Venture Partners and Versant Ventures.